DIRECTOR
Ryutaro Nakagawa
Representative Director (CentralMedience Inc.) / Manager, Certified M&A Support Institution by the Small and Medium Enterprise Agency
Head of “M&A Medical,” a specialized M&A advisory service for the healthcare industry. Engaged in business succession support for hospitals, medical corporations, and clinics, designing optimal succession schemes from both seller and buyer perspectives. Leads “CentralMedience,” a healthcare group involved in medical supply sales, human resource dispatch, and health management support.
Areas of Expertise
- Strategic planning for M&A in hospital and medical corporation business succession
- Designing schemes for transfer of equity interests and changes in membership for medical corporations
- Transition strategies for specific medical corporations and social medical corporations
- Healthcare industry due diligence (financial, legal, labor, medical practice)
- Post-succession group management integration (PMI)
- Ancillary support for medical supplies, human resources, and financing
Qualifications & Certifications
- Certified M&A Support Institution by the Small and Medium Enterprise Agency (CentralMedience Inc.)
- Practical experience in M&A advisory for the healthcare industry
Writings & Contributed Articles
Through the “Medical Succession Column” on M&A Medical, we continuously share practical knowledge essential for the field, covering topics such as successor shortages, market prices for transfers, tax schemes, and characteristics specific to medical departments.
Affiliated Organization
CentralMedience Inc.
SOUTH PORT Shinagawa 8F, 2-12-32 Konan, Minato-ku, Tokyo 108-0075
TEL: 03-5544-9120
Web: https://centralmedience.com/
Related Pages
- Medical Succession Guide — Methods for hospital and clinic succession
- How to Proceed with Hospital Succession
- How to Proceed with Clinic Succession
- Medical Succession Column — Sharing expert knowledge
Inquiries Regarding Medical M&A
Strict Confidentiality, Free Initial Consultation, Success-Based Fee